At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 55 enrolled
Drug / intervention
Percutaneous mitral valve repair (MitraClip Implant)device
Likely dose
Percutaneous mitral valve repair using the Evalve MitraClip Cardiovascular Valve Repair System (endovascular implant)AI-extracted
Key inclusion· 3
- ✓Moderate to severe mitral regurgitation, symptomatic or asymptomatic with evidence of left ventricular dysfunction
- ✓Regurgitation originates from the central two-thirds of the valve
- ✓Qualify as a candidate for mitral valve surgery including cardiopulmonary bypass
Key exclusion· 4
- ✕Ejection fraction less than 30%
- ✕Endocarditis
- ✕Rheumatic heart disease
- ✕Renal insufficiency
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Study of the Evalve Cardiovascular Valve Repair System Endovascular Valve Edge-to-Edge REpair STudy (EVEREST I).
In Brief
A Phase 2 clinical trial evaluating Percutaneous mitral valve repair (MitraClip Implant) for Mitral Valve Insufficiency and 4 related conditions. Completed, enrolled 55 participants across 1 site.
Detailed Summary
Prospective, multi-center, Phase I study of the Evalve Cardiovascular Valve Repair System (CVRS) in the treatment of mitral valve regurgitation. Patients will undergo 30-day, 6 month, 12 month, and 5 year clinical follow-up.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMitral Valve Insufficiency, Mitral Valve Regurgitation, Mitral Valve Incompetence, Mitral Regurgitation, Mitral Insufficiency
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2003
First PostedSep 2005
Primary CompletionFeb 2006
Study CompletionOct 2011
TodayJul 2026
First PostedSep 21, 2005
Enrollment StartJul 1, 2003
Primary CompletionFeb 1, 2006
Study CompletionOct 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 20.8 years ago
Interventions
Percutaneous mitral valve repair (MitraClip Implant)device
Phase I evaluation of the safety and effectiveness of an endovascular approach to the repair of mitral valve regurgitation using the Evalve MitraClip Cardiovascular Valve Repair System.